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____________________________________________________________________________________ 
Advances in medical therapies has advanced significantly in the last 25 years with the exception 
of those targeting microorganisms. The developments in antibiotics in the first half of the 20th 
century was very robust, but selective pressures have enriched bacterial populations for 
resistance. In order for the scientific community to maintain the ability to keep pathogens in 
control depends on the development of new and novel antibiotics. For my project I am 
developing a reactive oxygen species (ROS) sensitive green fluorescent protein (GFP) that can 
be expressed in E. coli and Candida albicans. My system will be able to identify novel 
antibiotic and antifungal compounds. The question I would like to answer is whether I can 
develop a ROS-sensitive GFP that has increased specificity to ROS by eliminating cysteines 
unrelated to our experimental design. This biosensor utilizes changes to two proximal amino 
acids to cysteines (S147C and Q204C) made using Quik-change mutagenesis. Mass 
spectroscopy and sequencing will check if the mutation occurred correctly. In the presence of 
ROS, these two cysteines form a disulfide bridge distorting the excitation of GFP. We can 
detect this using the clear bottom plates and the plate reader to see if there is a gain or loss of 
fluorescence. The percent change in fluorescence can show the presence of ROS. In addition to 
these mutations, there are two natural cysteines at positions 48 and 70 in GFP that under an 
oxidizing environment will form disulfide bridges with other proteins, complicating the analysis 
of our biosensor. Several groups have altered these cysteines to different amino acids in order to 
eliminate the oligomerization of GFP. Unfortunately, some of the amino acid substitutions have 
shown negative affects on the fluorescence (1). The goal of this project is to replace these two 
natural cysteines while maintaining the fluorescence of GFP. Alanine and serine substitutions 
have been shown to decrease fluorescence, while hydrophobic substitutions, valine and 
isoleucine, have been suggested to maintain fluorescence (2). In addition to valine and 
isoleucine, we will introduce leucine, methionine and phenylalanine. I will use combinations of 
these amino acids to mutate positions 48 and 70 and test these using a fluorescence plate reader 
to identify mutants that maintain wild type fluorescence followed by testing under oxidizing 
conditions using western blot analysis to detect oligomerization. With a functional ROS-
sensitive GFP biosensor, novel antibiotics can be identified that can be used properly without 
increasing ROS. Furthermore, this biosensor can be widely used at discovering other molecules 
in the cells that also increase ROS. 
 
 
 
 
